Back to news
July 11, 2022 | News

Scarlet Health’s Justin Bulova Joins Panel at HITLAB Symposium

Scarlet webinar graphic

Justin Bulova, of Scarlet Health®, a division of BioReference Laboratories, joined a panel at a recent HITLAB Digital Health symposium: Innovation Collaborations, The Future of Digital Health & The Metaverse. Bulova and panel participants, Fred Kopplow, executive with BetterHealthcare, and Howard Rosen, thought-leader with the Forbes Council, discussed how telehealth innovators can collaborate to bring patients a healthcare experience that meets the needs and demands of consumers. HITLAB is an organization that aims to disrupt and improve health technology and the delivery of healthcare around the world.

You can watch the full 15-minute discussion here.

Meeting the Needs of Healthcare Consumers

As investment in telehealth continues to grow and more telehealth services become available for patients, the panelists agreed that collaboration with all users and stakeholders is necessary when designing telehealth solutions – including engaging the patient. Digital solutions that engage patients in the development process are far more successful in terms of becoming a solution that patients understand and use for their healthcare needs.

As Bulova noted, this is where Scarlet® excels. Many digital solutions have high friction and low rates of success in terms of user satisfaction. Scarlet aims to provide a service to patients that is as seamless as possible and that creates additional pathways of access to bridge gaps in care. Scarlet’s mobile phlebotomy solution meets patients where they are and Bulova stated that there’s a team dedicated to actively listening and responding to the voice of the customer. By being laser focused on Scarlet’s customer feedback and input, the digital design teams can continue to shape an experience from which  the patient gains the highest benefit.

Strengthening the Care Continuum

Ordered and completed lab testing finishes the last medical mile according to Bulova, which can lead to better health outcomes. He emphasized that Scarlet’s fully integrated digital health experience allows patients to stay home and conveniently receive phlebotomy services. He also cited that 70 percent of healthcare decisions rely on laboratory diagnostic test results, making completed test results critical information for patients and the ordering physician and a core part of healthcare delivery.

The panel participants all agreed that patients are now consumers of healthcare and that healthcare companies ought to service consumers in ways that accommodate them in today’s world. Patients continue to become better educated about their health and the choices that are available to them. Conclusively, the consensus was that the future of digital health and health tech will require collaboration for all parts of the healthcare system to work together; and that includes the patient’s participation that can help strengthen the care continuum.